GLP-1 Trends Informing Holistic Kidney Care

Nov. 20, 2025

GLP-1s, once seen primarily through the lens of type two diabetes management, are now being recognized for their profound protective benefits for both cardiovascular and kidney health. Now, the healthcare community is leveraging evolving research to engage in a broad re-evaluation of how it manages costly chronic...

READ MORE

Press Releases
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
Mar 18, 2026

Disclaimer: The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the...

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference
Feb 24, 2026

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with...

DaVita Inc. 4th Quarter 2025 Results
Feb 2, 2026

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality,...

Read more